Distribution of PAI-1 promoter 4G/5G polymorphism in healthy Chinese and functional characterization using a luciferase reporter vector

Annals of Hematology

Volumn 84, Issue 3, 2005, Pages 183-187

  Ding, Zhongren ^a,b   Pan, Jia Qi ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell line; China; Gene expression regulation; Genotype; Plasminogen activator inhibitor 1; Polymorphism; Promoter regions

Indexed keywords

INTERLEUKIN 1; LUCIFERASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN;

ALLELE; ARTICLE; BLOOD SAMPLING; CELL STRAIN HEPG2; CELLULAR DISTRIBUTION; CHINESE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC TRANSCRIPTION; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MOLECULAR CLONING; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN POLYMORPHISM; REPORTER GENE;

CELL LINE, TUMOR; CHINA; GENE FREQUENCY; GENES, REPORTER; GENOTYPE; HUMANS; INTERLEUKIN-1; LUCIFERASES; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); THROMBIN; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 13844319436     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-004-0926-z     Document Type: Article

References (23)

1. Aucella F, Margaglione M, Vigilante M, Gatta G, Grandone E, Forcella M, Ktena M, De Min A, Salatino G, Procaccini DA, Stallone C (2003) PAI-1 4G/5G and ACE I/D gene polymorphisms and the occurrence of myocardial infarction in patients on intermittent dialysis. Nephrol Dial Transplant 18:1142-1146 10.1093/ndt/gfg118
2. Burzotta F, Di Castelnuovo A, Amore C, D'Orazio A, Di Bitondo R, Donati MB, Iacoviello L (1998) 4G/5G promoter PAI-1 gene polymorphism is associated with plasmatic PAI-1 activity in Italians: A model of gene-environment interaction. Thromb Haemost 79:354-358 1:CAS:528:DyaK1cXhtVeis70%3D
3. Canavy I, Henry M, Morange PE, Tiret L, Poirier O, Ebagosti A, Bory M, Juhan-Vague I (2000) Genetic polymorphisms and coronary artery disease in the south of France. Thromb Haemost 83:212-216 1:CAS:528:DC%2BD3cXhtFWgt74%3D
4. Catto AJ, Carter AM, Stickland M, Bamford JM, Davies JA, Grant PJ (1997) Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease. Thromb Haemost 77:730-734 1:CAS:528:DyaK2sXislOjsb8%3D
5. Cesari M, Sartori MT, Patrassi GM, Vettore S, Rossi GP (1999) Determinants of plasma levels of plasminogen activator inhibitor-1: A study of normotensive twins. Arterioscler Thromb Vasc Biol 19:316-320 1:CAS:528:DyaK1MXhsFSjtLc%3D
6. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM (1993) The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 268:10739-10745 1:CAS:528:DyaK3sXkt1Kntr4%3D
7. Endler G, Lalouschek W, Exner M, Mitterbauer G, Haring D, Mannhalter C (2000) The 4G/4G genotype at nucleotide position -675 in the promotor region of the plasminogen activator inhibitor 1 (PAI-1) gene is less frequent in young patients with minor stroke than in controls. Br J Haematol 110:469-471 10.1046/j.1365-2141.2000.02164.x
8. Eriksson P, Kallin B, van't Hooft FM, Bavenholm P, Hamsten A (1995) Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A 92:1851-1855 1:CAS:528:DyaK2MXksVCru7g%3D
9. Festa A, D'Agostino R Jr, Rich SS, Jenny NS, Tracy RP, Haffner SM (2003) Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: The Insulin Resistance Atherosclerosis Study. Circulation 107:2422-2427 10.1161/01.CIR.0000066908.82782.3A
10. Francis CW (2002) Plasminogen activator inhibitor-1 levels and polymorphisms. Arch Pathol Lab Med 126:1401-1404 1:CAS:528:DC%2BD3sXhtFGgtrk%3D
11. van Harmelen V, Wahrenberg H, Eriksson P, Arner P (2000) Role of gender and genetic variance in plasminogen activator inhibitor-1 secretion from human adipose tissue. Thromb Haemost 83:304-308 10739390
12. Hooper WC, Lally C, Austin H, Renshaw M, Dilley A, Wenger NK, Phillips DJ, Whitsett C, Rawlins P, Evatt BL (2000) The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism. Thromb Res 99:223-230 10.1016/S0049-3848(00)00236-X
13. Jeng JR (2003) Association of PAI-1 gene promoter 4g/5g polymorphism with plasma PAI-1 activity in Chinese patients with and without hypertension. Am J Hypertens 16:290-296 10.1016/S0895-7061(03)00004-9
14. Leander K, Wiman B, Hallqvist J, Sten-Linder M, De Faire U (2003) PAI-1 level and the PAI-1 4G/5G polymorphism in relation to risk of non-fatal myocardial infarction. Thromb Haemost 89:1064-1071 1:CAS:528:DC%2BD3sXlt1KqtLc%3D
15. Liu S, Yang L, Wang X, Li X, Sun Z (1998) The study of the plasma PAI-1 activity and its promotor region gene polymorphism in acute cerebral infarction. Chin J Neurol 3:264-266
16. Mansfield MW, Stickland MH, Grant PJ (1995) Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes. Thromb Haemost 74:1032-10341:CAS:528:DyaK2MXptVyiu7w%3D
17. Matsubara Y, Murata M, Isshiki I, Watanabe R, Zama T, Watanabe G, Watanabe K, Ikeda Y (1999) Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels. Int J Hematol 69:43-47 1:CAS:528:DyaK1MXhtlygs74%3D
18. Panahloo A, Mohamed-Ali V, Gray RP, Humphries SE, Yudkin JS (2003) Plasminogen activator inhibitor-1 (PAI-1) activity post myocardial infarction: The role of acute phase reactants, insulin-like molecules and promoter (4G/5G) polymorphism in the PAI-1 gene. Atherosclerosis 168:297-304 10.1016/S0021-9150(03)00095-9
19. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Miletich JP (1997) Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men. Circulation 95:59-62 1:STN:280:ByiC2cjmsVE%3D
20. Roest M, van der Schouw YT, Banga JD, Tempelman MJ, de Groot PG, Sixma JJ, Grobbee DE (2000) Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women. Circulation 101:67-70 1:CAS:528:DC%2BD3cXnt1Wiuw%3D%3D
21. Song J, Yoon YM, Jung HJ, Hong SH, Park H, Kim JQ (2000) Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and coagulation factor VII Arg353→Gln polymorphism in Korean patients with coronary artery disease. J Korean Med Sci 15:146-152 1:CAS:528:DC%2BD3cXjtlyksr4%3D
22. van der Bom JG, Bots ML, Haverkate F, Kluft C, Grobbee DE (2002) The 4G5G polymorphism in the gene for PAI-1 and the circadian oscillation of plasma PAI-1. Blood 101:1841-1844 10.1182/blood-2002-07-2181
23. Wong TY, Poon P, Szeto CC, Chan JC, Li PK (2000) Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients. Kidney Int 57:632-638 10.1046/j.1523-1755.2000.00884.x